DMCAS学习顾问
资料研究员
24粉丝｜0关注
Epidemiology and Practice Patterns of Achalasia in a Large Multi-Center Database
Epidemiology and Practice Patterns of Achalasia in a Large Multi-Center Database
2710 0 19.90元
Two Mechanisms Involved in Trigeminal CGRP Release: Implications for Migraine Treatment
Two Mechanisms Involved in Trigeminal CGRP Release: Implications for Migraine Treatment
2695 0 19.90元
Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine
Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine
2395 0 19.90元
A Single-blind, Split-face, Randomized, Pilot Study Comparing the Effects of Intradermal and
A Single-blind, Split-face, Randomized, Pilot Study Comparing the Effects of Intradermal and
3940 0 19.90元
OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine
OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine
2787 0 19.90元
Healing of rotator cuff tendons using botulinum toxin A and immobilization in a rat model
Healing of rotator cuff tendons using botulinum toxin A and immobilization in a rat model
2996 0 19.90元
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic
2441 0 19.90元
Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of
Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of
2429 0 19.90元
Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
2529 0 19.90元
OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and
OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and
2851 0 19.90元
Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from
Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from
3128 0 19.90元
Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’
Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’
2783 0 19.90元
Pharmacological differences and clinical implications of various botulinum toxin preparations
Pharmacological differences and clinical implications of various botulinum toxin preparations
3034 0 19.90元
Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder
Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder
2927 0 19.90元
A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25
A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25
2440 0 19.90元
Use of botulinum toxin in individuals with neurogenic detrusor overactivity: State of the art review
Use of botulinum toxin in individuals with neurogenic detrusor overactivity: State of the art review
2391 0 19.90元
Cellular and Matrix Response of the Mandibular Condylar Cartilage to Botulinum Toxin
Cellular and Matrix Response of the Mandibular Condylar Cartilage to Botulinum Toxin
2750 0 19.90元
A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in
A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in
2421 0 19.90元
Insights Into the Mechanism of OnabotulinumtoxinA in Chronic Migraine
Insights Into the Mechanism of OnabotulinumtoxinA in Chronic Migraine
1892 0 19.90元
Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic
Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic
2363 0 19.90元